About Pharmaq
Pharmaq is a company based in Oslo (Norway) founded in 2004 was acquired by Zoetis in November 2015. The company has 213 employees as of December 31, 2020. Pharmaq has completed 2 acquisitions, including Fish Vet Group and Nordland Set Vaks. Pharmaq offers products and services including Fish Vaccines and Vaccination Equipment.
- Headquarter Oslo, Norway
- Employees 213 as on 31 Dec, 2020
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmaq As
-
Annual Revenue
$843.9 M (USD)4as on Dec 31, 2022
-
Net Profit
$220.79 M (USD)4as on Dec 31, 2022
-
EBITDA
$220.48 M (USD)4as on Dec 31, 2022
-
Latest Funding Round
Not available
-
Investors
Zoetis
& 5 more
-
Employee Count
213
as on Dec 31, 2020
-
Investments & Acquisitions
Fish Vet Group
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharmaq
Pharmaq offers a comprehensive portfolio of products and services, including Fish Vaccines and Vaccination Equipment.
Vaccines for fish are developed and supplied by PHARMAQ to prevent diseases and improve welfare in aquaculture settings
Vaccination tools and related services are offered by PHARMAQ to facilitate fish health management in commercial operations
Funding Insights of Pharmaq
Investors in Pharmaq
Pharmaq has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Zoetis, Permira and Orkla.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Locked | Locked | Locked | |
|
Kverva is focused on investments in the marine sector.
|
Locked | Locked | Locked | |
|
Consulting services in agriculture, travel, and international investments are offered.
|
Locked | Locked | Locked |
Investor details for Pharmaq
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmaq
Pharmaq has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Fish Vet Group and Nordland Set Vaks.
Investment portfolio details for Pharmaq
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Veterinary healthcare research services for fish are provided.
|
Locked | Locked | 1995 | Locked | |
|
Machinery for fish vaccination is manufactured and supplied.
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for Pharmaq
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Pharmaq
Detailed financials for Pharmaq
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmaq Comparisons
Peer comparison for Pharmaq
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharmaq
Detailed competitors of Pharmaq
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmaq
Complete news archive for Pharmaq
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmaq
Pharmaq was founded in 2004 and raised its 1st funding round 4 years after it was founded.
Pharmaq is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
As of Dec 31, 2020, the latest employee count at Pharmaq is 213.
Annual revenue of Pharmaq is $843.9M as on Dec 31, 2022.
Pharmaq was founded in 2004 in Oslo, Norway, focusing on the aquaculture sector. Vaccines and therapeutics are developed and manufactured to address fish diseases. Vaccination machinery and equipment are produced to facilitate administration processes. Diagnostic services, along with research-informed advice, are offered to support fish health and welfare. These activities contribute to sustainable operations within the global aquaculture industry.
Pharmaq offers Fish Vaccines and Vaccination Equipment.
Pharmaq has made 2 acquisitions, including Fish Vet Group, and Nordland Set Vaks.
Pharmaq has 6 investors. Key investors include Zoetis, Permira, Orkla, Innovasjon Norge, and Norad.